Search research articles
Contact Us
Filters
Showing results (271-280 of 280) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 280 results.
Materials Today. Bio
|
May 13, 2026
A flaxseed oil body-based delivery system integrating calcium overload and lipid peroxidation for immunogenic cell death-driven immunotherapy
Xiaoxiao Chen, Hongkai Qi, Fengkai Qiu, et al.
Exploration (Beijing, China)
|
October 30, 2025
A 3.55-µm Ultrathin, Skin-Like Mechanoresponsive, Compliant, and Seamless Ionic Conductive Electrode for Epidermal Electrophysiological Signal Acquisition and Human-Machine Interaction
Likun Zhang, Peiwu Qin, Huazhang Ying, et al.
Science Advances
|
July 2, 2025
Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study
Fei Gong, Liyun Zheng, Jiachen Xu, et al.
Translational Lung Cancer Research
|
June 19, 2025
Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations
Xiaobei Guo, Hui Zhang, Yuequan Shi, et al.
Chinese Medical Journal
|
May 25, 2025
Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study
Yuequan Shi, Xiaoyan Liu, Anwen Liu, et al.
NPJ Digital Medicine
|
July 13, 2025
Diagnosing pathologic myopia by identifying morphologic patterns using ultra widefield images with deep learning
Yang Liu, Keming Zhao, Lihui Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study
Minjiang Chen, Iurie Bulat, Marina Maglakelidze, et al.
Thoracic Cancer
|
May 31, 2019
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study
Hongge Liang, Xia Song, Yuhui Zhang, et al.
Thoracic Cancer
|
December 22, 2021
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
Yuequan Shi, Jian Fang, Chengzhi Zhou, et al.
Translational Lung Cancer Research
|
December 13, 2023
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced <i>EGFR</i>-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study
Dongming Zhang, Xiaoyan Liu, Fangfang Shen, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 280) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 280 results.
Materials Today. Bio
|
May 13, 2026
A flaxseed oil body-based delivery system integrating calcium overload and lipid peroxidation for immunogenic cell death-driven immunotherapy
Xiaoxiao Chen, Hongkai Qi, Fengkai Qiu, et al.
Exploration (Beijing, China)
|
October 30, 2025
A 3.55-µm Ultrathin, Skin-Like Mechanoresponsive, Compliant, and Seamless Ionic Conductive Electrode for Epidermal Electrophysiological Signal Acquisition and Human-Machine Interaction
Likun Zhang, Peiwu Qin, Huazhang Ying, et al.
Science Advances
|
July 2, 2025
Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study
Fei Gong, Liyun Zheng, Jiachen Xu, et al.
Translational Lung Cancer Research
|
June 19, 2025
Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations
Xiaobei Guo, Hui Zhang, Yuequan Shi, et al.
Chinese Medical Journal
|
May 25, 2025
Programmed death-ligand 1 tumor proportion score in predicting the safety and efficacy of PD-1/PD-L1 antibody-based therapy in patients with advanced non-small cell lung cancer: A retrospective, multicenter, observational study
Yuequan Shi, Xiaoyan Liu, Anwen Liu, et al.
NPJ Digital Medicine
|
July 13, 2025
Diagnosing pathologic myopia by identifying morphologic patterns using ultra widefield images with deep learning
Yang Liu, Keming Zhao, Lihui Luo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2026
Subcutaneously Administered Tislelizumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer: Pharmacokinetics and Safety Results from the BGB-A317-103 Phase I Study
Minjiang Chen, Iurie Bulat, Marina Maglakelidze, et al.
Thoracic Cancer
|
May 31, 2019
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study
Hongge Liang, Xia Song, Yuhui Zhang, et al.
Thoracic Cancer
|
December 22, 2021
Immune checkpoint inhibitor-related adverse events in lung cancer: Real-world incidence and management practices of 1905 patients in China
Yuequan Shi, Jian Fang, Chengzhi Zhou, et al.
Translational Lung Cancer Research
|
December 13, 2023
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced <i>EGFR</i>-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study
Dongming Zhang, Xiaoyan Liu, Fangfang Shen, et al.
Page
of 28